United KingdomA recent report reveals that weight loss injections like Mounjaro and Wegovy have been linked to at least 216 deaths in the UK, with fatalities increasing by 300% over the past year. The majority of these deaths involved tirzepatide, the active ingredient in Mounjaro. Data from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) indicates that 150,000 adverse reactions have been reported since 2010, including 18,000 serious cases. Many of these incidents involve gastrointestinal complications such as pancreatitis and gastroparesis. A case involving a 73-year-old woman who died after increasing her Mounjaro dosage highlights concerns about rare but potentially fatal side effects like bowel perforation leading to sepsis. Experts warn that while these complications are not common, they can be severe and require immediate attention. The MHRA collects reports through its Yellow Card scheme, though these reports only indicate suspicion rather than proof of causation.
Bias read (Progressive): The article emphasizes the risks associated with weight loss injections, particularly highlighting the increased mortality rate and specific dangers tied to tirzepatide. While it presents factual data from official sources, the framing leans toward caution and concern, suggesting regulatory scrutiny
